During the 15th Annual Healthcare Industry Leadership Virtual Conference, A&M experts discussed how COVID-19 has propelled the biotech and pharmaceutical industry – vaccine production, research and innovation and opportunities for investment – tenfold in just a few short months.
In this session, the panelists also discussed:
- Near- and long-term industry outlook
- Expanded patient access for clinical trials
- Developing regulatory challenges
- Emerging players and platforms
- Expanding role for telehealth
Panel Moderator:
Dr. Keith Ghezzi, Managing Director, A&M Healthcare Industry Group
Speakers:
Jacques Mulder, former Managing Director, A&M Healthcare Industry Group
Peter Urbanowicz, Managing Director and Co-Head of A&M's Healthcare Industry Group
Watch the other panel sessions here:
Healthcare Systems in the COVID-19 Era
Diversity & Inclusion in Healthcare Organizations
Dr. Chad Perlyn is Building Clinicians of the Future as He Leads NSU Florida's AMC
March 12, 2026
How do we prepare tomorrow's physicians for a system defined by constant change? Chad Perlyn, M.D., PhD, FACS, EVP and Chief Medical Officer of NSU Florida and Dean of NSU MD, joins A&M Healthcare Industry Group's Jamie LaGuardia-Frie and David Shulkin, M.D. to share how their academic medical center is reimagining education to prepare physicians for a rapidly evolving healthcare landscape.
Health System Pulse Survey: Medicare Advantage Is No Longer a Growth Strategy — It’s a Capital Allocation Decision
March 4, 2026
MA is no longer a growth strategy; it is a capital allocation and operating model decision. The question for health system CEOs and CFOs is not how to manage MA better, but whether, where, and how to participate at all.
Why Private Equity Works in Value-Based Primary Care
February 2, 2026
Private equity’s influence in value‑based primary care is widely debated, but new evidence shows a different reality. This analysis gives healthcare leaders clarity on where disciplined capital strengthens care models, and where it doesn’t.
The State of Transformation for U.S. Healthcare Providers
January 26, 2026
Market dynamics for health systems are shifting. The most significant driver is the federal Medicaid mandate, which expired at the end of December 2025 and is now pending legislation. This uncertainty is prompting health system leaders to rethink strategy and operations. In this context, we’ll share how other health systems are responding and what these changes mean for organizations like yours.
